The efficacy and safety of tivantinib in the treatment of solid tumors: a systematic review and meta-analysis

BACKGROUND: Tivantinib was designed to kill cancers by targeting the mesenchymal-epithelial transition (MET) protein. Although numerous tivantinib clinical trials are ongoing, tivantinib's efficacy and safety are still not clear. This meta-analysis was done to evaluate tivantinib's efficac...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Hao, Bao, Zhengqiang, Liao, Hongwei, Li, Wen, Chen, Zhihua, Shen, Huahao, Ying, Songmin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762579/
https://www.ncbi.nlm.nih.gov/pubmed/29348894
http://dx.doi.org/10.18632/oncotarget.22615

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762579/
https://www.ncbi.nlm.nih.gov/pubmed/29348894
http://dx.doi.org/10.18632/oncotarget.22615

Ejemplares similares